{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:39:40Z","timestamp":1787657980418,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The anti-mesothelioma mAb SKM9-2 recognizes the sialylated protein HEG homolog 1 (HEG1). HEG1 is a 400\u2009kDa mucin-like membrane protein found on mesothelioma. SKM9-2 can detect mesothelioma more specifically and sensitively than other antibodies against current mesothelioma markers; therefore, SKM9-2 would be likely useful for the precise detection and diagnosis of malignant mesothelioma. In the present study, we investigated the epitope of SKM9-2. We analyzed the binding of SKM9-2 to truncated HEG1 and candidate epitope-fused glycosylphosphatidylinositol-anchor proteins. The epitope of SKM9-2 was identified as an <jats:italic>O<\/jats:italic>-glycosylated region, 893-SKSPSLVSLPT-903, in HEG1. An alanine scanning assay of the epitope showed that SKM9-2 bound to a simple epitope in HEG1, and the SKxPSxVS sequence within the epitope was essential for SKM9-2 recognition. Mass spectrometry analysis and lectin binding analysis of soluble epitope peptides indicated that the SKM9-2 epitope, in which Ser<jats:sup>897<\/jats:sup> was not glycosylated, contained two disialylated core 1 <jats:italic>O<\/jats:italic>-linked glycan-modified serine residues, Ser<jats:sup>893<\/jats:sup> and Ser<jats:sup>900<\/jats:sup>. Neuraminidase treatment analysis also confirmed that the epitope in mesothelioma cells contained a similar glycan modification. The specific detection of mesothelioma with SKM9-2 can thus be performed by the recognition of sialylated glycan modification in the specific region of HEG1.<\/jats:p>","DOI":"10.1038\/s41598-018-32534-8","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T10:22:21Z","timestamp":1537266141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Identification of mesothelioma-specific sialylated epitope recognized with monoclonal antibody SKM9-2 in a mucin-like membrane protein HEG1"],"prefix":"10.1038","volume":"8","author":[{"given":"Rieko","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-9999","authenticated-orcid":false,"given":"Hiroyuki","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Narimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Moriwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzoh","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoutaro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"32534_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth, M. A. & Swanson, B. J. Mucins in cancer: Protection and control of the cell surface. Nat. Rev. Cancer 4, 45\u201360 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"32534_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/biof.64","volume":"35","author":"S Rachagani","year":"2009","unstructured":"Rachagani, S., Torres, M. P., Moniaux, N. & Batra, S. K. Current status of mucins in the diagnosis and therapy of cancer. Biofactors 35, 509\u2013527 (2009).","journal-title":"Biofactors"},{"key":"32534_CR3","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1073\/pnas.0710412105","volume":"105","author":"K Amano","year":"2008","unstructured":"Amano, K. et al. Engineering of mucin-type human glycoproteins in yeast cells. Proc. Natl. Acad. Sci. USA 105, 3232\u20133237 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"32534_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.embor.7400705","volume":"7","author":"I Brockhausen","year":"2006","unstructured":"Brockhausen, I. & Mucin-type O-glycansin human colon and breast cancer: glycodynamics and functions. EMBO Rep. 7, 599\u2013604 (2006).","journal-title":"EMBO Rep."},{"key":"32534_CR5","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1073\/pnas.0407983102","volume":"102","author":"T Iwai","year":"2005","unstructured":"Iwai, T. et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc. Natl. Acad. Sci. USA 102, 4572\u20134577 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"32534_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/vaccines4030025","volume":"4","author":"MK Hossain","year":"2016","unstructured":"Hossain, M. K. & Wall, K. A. Immunological evaluation of recent MUC1 glycopeptide cancer vaccines. Vaccines 4, 25 (2016).","journal-title":"Vaccines"},{"key":"32534_CR7","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/glycob\/cws082","volume":"22","author":"Y Tian","year":"2012","unstructured":"Tian, Y. et al. Mucin 21 in esophageal squamous epithelia and carcinomas: analysis with glycoform-specific monoclonal antibodies. Glycobiology 22, 1218\u20131226 (2012).","journal-title":"Glycobiology"},{"key":"32534_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/anie.201002313","volume":"50","author":"T Ju","year":"2011","unstructured":"Ju, T., Otto, V. I. & Cummings, R. D. The Tn antigen-structural simplicity and biological complexity. Angew. Chem. Int. Ed. Engl. 50, 1770\u20131791 (2011).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"32534_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.canlet.2013.10.005","volume":"352","author":"V Padler-Karavani","year":"2014","unstructured":"Padler-Karavani, V. Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine. Cancer Lett. 352, 102\u2013112 (2014).","journal-title":"Cancer Lett."},{"key":"32534_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: Mechanisms and clinical implications. Nat. Rev. Cancer 15, 540\u2013555 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"32534_CR11","first-page":"220","volume":"3","author":"Y Inagaki","year":"2009","unstructured":"Inagaki, Y. et al. Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers. BioSci. Trends 3, 220\u2013232 (2009).","journal-title":"BioSci. Trends"},{"key":"32534_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep05924","volume":"4","author":"Y Kato","year":"2014","unstructured":"Kato, Y. & Kaneko, M. K. A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated podoplanin. Sci. Rep. 4, 5924 (2014).","journal-title":"Sci. Rep."},{"key":"32534_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone, M. et al. Malignant mesothelioma: facts, myths, and hypotheses. J. Cell. Physiol. 227, 44\u201358 (2012).","journal-title":"J. Cell. Physiol."},{"key":"32534_CR14","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.21037\/jtd.2017.10.125","volume":"10","author":"G Al\u00ec","year":"2018","unstructured":"Al\u00ec, G., Bruno, R. & Fontanini, G. The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review. J. Thorac. Dis. 10, S276\u2013S284 (2018).","journal-title":"J. Thorac. Dis."},{"key":"32534_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep45768","volume":"7","author":"S Tsuji","year":"2017","unstructured":"Tsuji, S. et al. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci. Rep. 7, 45768 (2017).","journal-title":"Sci. Rep."},{"key":"32534_CR16","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cub.2003.11.055","volume":"13","author":"JD Mably","year":"2003","unstructured":"Mably, J. D., Mohideen, M. A., Burns, C. G., Chen, J. N. & Fishman, M. C. heart of glass regulates the concentric growth of the heart in zebrafish. Curr. Biol. 13, 2138\u20132147 (2003).","journal-title":"Curr. Biol."},{"key":"32534_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nm.1918","volume":"15","author":"B Kleaveland","year":"2009","unstructured":"Kleaveland, B. et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 15, 169\u2013176 (2009).","journal-title":"Nat. Med."},{"key":"32534_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neures.2009.04.014","volume":"64","author":"Y Moriwaki","year":"2009","unstructured":"Moriwaki, Y. et al. Primary sensory neuronal expression of SLURP-1, an endogenous nicotinic acetylcholine receptor ligand. Neurosci. Res. 64, 403\u2013412 (2009).","journal-title":"Neurosci. Res."},{"key":"32534_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1074\/mcp.M800308-MCP200","volume":"8","author":"A Kuno","year":"2009","unstructured":"Kuno, A. et al. Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification. Mol. Cell. Proteomics 8, 99\u2013108 (2009).","journal-title":"Mol. Cell. Proteomics"},{"key":"32534_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1023\/A:1006935331756","volume":"15","author":"S Ogata","year":"1998","unstructured":"Ogata, S. et al. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj. J. 15, 29\u201335 (1998).","journal-title":"Glycoconj. J."},{"key":"32534_CR21","doi-asserted-by":"publisher","first-page":"871936","DOI":"10.1155\/2013\/871936","volume":"2013","author":"D Roulois","year":"2013","unstructured":"Roulois, D., Gr\u00e9goire, M. & Fonteneau, J. F. MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge. Biomed. Res. Int. 2013, 871936 (2013).","journal-title":"Biomed. Res. Int."},{"key":"32534_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/glycob\/cwh090","volume":"14","author":"U Karsten","year":"2004","unstructured":"Karsten, U., Serttas, N., Paulsen, H., Danielczyk, A. & Goletz, S. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1). Glycobiology 14, 681\u2013692 (2004).","journal-title":"Glycobiology"},{"key":"32534_CR23","doi-asserted-by":"publisher","first-page":"e0152912","DOI":"10.1371\/journal.pone.0152912","volume":"11","author":"Y Kato","year":"2016","unstructured":"Kato, Y. et al. LpMab-12 Established by CasMab technology specifically detects sialylated O-Glycan on Thr52 of platelet aggregation-stimulating domain of human podoplanin. PLoS One 11, e0152912 (2016).","journal-title":"PLoS One"},{"key":"32534_CR24","doi-asserted-by":"publisher","first-page":"M111.007898","DOI":"10.1074\/mcp.M111.007898","volume":"10","author":"A de Laurentiis","year":"2011","unstructured":"de Laurentiis, A. et al. Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein. Mol. Cell. Proteomics 10, M111.007898 (2011).","journal-title":"Mol. Cell. Proteomics"},{"key":"32534_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/glycob\/cwr118","volume":"22","author":"A Seko","year":"2012","unstructured":"Seko, A., Ohkura, T., Ideo, H. & Yamashita, K. Novel O-linked glycans containing 6\u2032-sulfo-Gal\/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6 (MUC1) monoclonal antibody. Glycobiology 22, 181\u2013195 (2012).","journal-title":"Glycobiology"},{"key":"32534_CR26","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/molecules23061326","volume":"23","author":"D Zhou","year":"2018","unstructured":"Zhou, D., Xu, L., Huang, W. & Tonn, T. Epitopes of MUC1 tandem repeats in cancer as revealed by antibody crystallography: toward glycopeptide signature-guided therapy. Molecules 23, 1326 (2018).","journal-title":"Molecules"},{"key":"32534_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0300-9084(01)01309-8","volume":"83","author":"A Varki","year":"2001","unstructured":"Varki, A. N-glycolylneuraminic acid deficiency in humans. Biochimie 83, 615\u2013622 (2001).","journal-title":"Biochimie"},{"key":"32534_CR28","unstructured":"Varki, A. & Schauer, R. Sialic acids in Essentials of glycobiology. 2nd edition (ed. Varki, A. et al.). Chapter 14. 199\u2013217 (Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 2009)."},{"key":"32534_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/978-1-4419-7877-6_28","volume":"705","author":"R Schauer","year":"2011","unstructured":"Schauer, R., Srinivasan, G. V., Wipfler, D., Kniep, B. & Schwartz-Albiez, R. O-Acetylated sialic acids and their role in immune defense. Adv. Exp. Med. Biol. 705, 525\u2013548 (2011).","journal-title":"Adv. Exp. Med. Biol."},{"key":"32534_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/glycob\/cwr106","volume":"22","author":"C Mandal","year":"2012","unstructured":"Mandal, C., Mandal, C., Chandra, S., Schauer, R. & Mandal, C. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia. Glycobiology 22, 70\u201383 (2012).","journal-title":"Glycobiology"},{"key":"32534_CR31","first-page":"33","volume":"4","author":"AN Samraj","year":"2014","unstructured":"Samraj, A. N., L\u00e4ubli, H., Varki, N. & Varki, A. Involvement of a non-human sialic acid in human cancer. Front. Oncol. 4, 33 (2014).","journal-title":"Front. Oncol."},{"key":"32534_CR32","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.celrep.2015.05.044","volume":"11","author":"MA Langereis","year":"2015","unstructured":"Langereis, M. A. et al. Complexity and diversity of the mammalian sialome revealed by nidovirus virolectins. Cell Rep. 11, 1966\u20131978 (2015).","journal-title":"Cell Rep."},{"key":"32534_CR33","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1021\/ja072181b","volume":"129","author":"F Corzana","year":"2007","unstructured":"Corzana, F. et al. Serine versus threonine glycosylation: the methyl group causes a drastic alteration on the carbohydrate orientation and on the surrounding water shell. J. Am. Chem. Soc. 129, 9458\u20139467 (2007).","journal-title":"J. Am. Chem. Soc."},{"key":"32534_CR34","doi-asserted-by":"publisher","first-page":"12616","DOI":"10.1002\/chem.201403700","volume":"20","author":"D Madariaga","year":"2014","unstructured":"Madariaga, D. et al. Serine versus threonine glycosylation with \u03b1-O-GalNAc: unexpected selectivity in their molecular recognition with lectins. Chemistry 20, 12616\u201312627 (2014).","journal-title":"Chemistry"},{"key":"32534_CR35","doi-asserted-by":"publisher","first-page":"9830","DOI":"10.1002\/anie.201502813","volume":"54","author":"N Mart\u00ednez-S\u00e1ez","year":"2015","unstructured":"Mart\u00ednez-S\u00e1ez, N. et al. Deciphering the non-equivalence of serine and threonine O-Glycosylation points: implications for molecular recognition of the Tn antigen by an anti-MUC1 antibody. Angew. Chem. Int. Ed. 54, 9830\u20139834 (2015).","journal-title":"Angew. Chem. Int. Ed."},{"key":"32534_CR36","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/emboj.2013.79","volume":"32","author":"C Steentoft","year":"2013","unstructured":"Steentoft, C. et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J. 32, 1478\u20131488 (2013).","journal-title":"EMBO J."},{"key":"32534_CR37","doi-asserted-by":"publisher","first-page":"14493","DOI":"10.1074\/jbc.M111.218701","volume":"286","author":"TA Gerken","year":"2011","unstructured":"Gerken, T. A. et al. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases. J. Biol. Chem. 286, 14493\u201314507 (2011).","journal-title":"J. Biol. Chem."},{"key":"32534_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","volume":"97","author":"N Usami","year":"2006","unstructured":"Usami, N. et al. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci. 97, 387\u2013394 (2006).","journal-title":"Cancer Sci."},{"key":"32534_CR39","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1093\/nar\/18.17.5322","volume":"18","author":"S Mizushima","year":"1990","unstructured":"Mizushima, S. & Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322 (1990).","journal-title":"Nucleic Acids Res."},{"key":"32534_CR40","first-page":"311","volume":"48","author":"WJ Waddell","year":"1956","unstructured":"Waddell, W. J. A simple UV spectrophotometric method for the determination of protein. J. Lab. Clin. Med. 48, 311\u2013314 (1956).","journal-title":"J. Lab. Clin. Med."},{"issue":"6","key":"32534_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s13361-018-1938-6","volume":"29","author":"Akira Togayachi","year":"2018","unstructured":"Togayachi, A. et al. Identification of poly-N-acetyllactosamine-carrying glycoproteins from HL-60 human promyelocytic leukemia cells using a site-specific glycome analysis method, Glyco-RIDGE. J. Am. Soc. Mass Spectrom. https:\/\/doi.org\/10.1007\/s13361-018-1938-6 (2018).","journal-title":"Journal of The American Society for Mass Spectrometry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32534-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32534-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32534-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:57:16Z","timestamp":1671616636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32534-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32534"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32534-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.M., S.T. and K.I. declare that they are inventors on a patent application (PCT\/JP2017\/001250) that covers the antibody against HEG1 and its usage. The application was submitted by Kanagawa Prefectural Hospital Organization and the University of Tokyo. S.T. and K.I. receive research grants from LSI Medience Co. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14251"}}